GCCL Completes Proactive Development of Biosimilar Clinical Trial Analysis Methods, Providing Customized Analysis Services through Enhanced R&D Capabilities
Newly established R&D division this year is expected to provide full-scale in-house R&D in addition to clinical sample analysis
Including blockbuster drugs such as ‘Keytruda’ and ‘Yervoy’, GCCL of… อ่านเพิ่ม